DELIVERING A NEW GENERATION OF INTEGRIN MEDICINES September 2021 Forward Looking Statements This presentation contains "forward-looking" statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Morphic's or our partners' plans to develop and commercialize oral small-molecule integrin therapeutics and Morphic's expectations about timing and ability to commence, enroll or complete clinical studies and to obtain regula ...